Showing posts with label World Bank. Show all posts
Showing posts with label World Bank. Show all posts

Friday, June 10, 2011

World Bank Study: Better HIV/AIDS Programs for Men Who Have Sex with Men Could Significantly Slow Global Epidemic

Source (press release, dated June 8, 2011)

On the eve of a UN summit to renew global efforts to reverse the HIV/AIDS pandemic, 30 years after the first discovery of the HIV virus, a new World Bank study urges governments and their development donors to provide better HIV prevention, care, and treatment services for men who have sex with men (MSM) as an essential step toward reversing the global epidemic. More than 25 million people have died of HIV/AIDS since the virus was first clinically identified in 1981.

Written in close partnership with the United Nations Development Programme (UNDP) and the Johns Hopkins Bloomberg School of Public Health, the new study―Global HIV Epidemics Among Men Who Have Sex with Men (MSM): Epidemiology, Prevention, Access to Care and Human Rights―provides the first comprehensive economic analysis of evidence that MSM are at significantly higher risk for HIV infection than other groups in many low- and middle-income countries, where fewer than 1 in 10 MSM worldwide have access to even basic HIV/AIDS prevention, care, and treatment services.

Research among MSM has been limited by social discrimination and the criminalization of their behavior, along with limited funding for HIV/AIDS programs that help MSM. The study suggests that these social factors make MSM vulnerable to HIV infection as well as limiting their access to HIV/AIDS treatment and care.

“We see that in many developing countries, the HIV/AIDS epidemic today looks like the early years of the epidemic in the West in the 1980s, when ignorance and stigma were rampant,” said David Wilson, Global HIV/AIDS Director at the World Bank. “This study provides the best evidence yet that failure to address MSM will continue to thwart efforts to reverse the global HIV/AIDS epidemic.”

The study authors identify four scenarios that describe the current state of the HIV epidemic among MSM in low- and middle-income countries, and assess the cost to improve the situation for MSM. The authors conclude that achieving high rates of coverage of HIV/AIDS prevention and treatment services among MSM has a significant positive impact on the overall trajectory of a country’s HIV epidemic.

The four regional scenarios are: 1 – Where MSM have the most numbers of HIV infection in the population (South America); 2 – Countries with large numbers of infections among intravenous drug users, in which infections among MSM are also substantial (Eastern Europe and Central Asia); 3 – MSM risks of infection occur within widespread HIV epidemics among heterosexuals (sub-Saharan Africa); and 4 – MSM, intravenous drug users, and heterosexual transmissions all contribute significantly to the HIV epidemic (Southeast Asia).

“In too many countries, the neglect of HIV epidemics among men who have sex with men has undermined the effectiveness of HIV responses,” said Jeff O’Malley, Director of UNDP’s HIV Group. “These new data offer development partners an opportunity to refocus their planning efforts and to ensure that HIV responses are in line with the burden of HIV in their countries.”

In Peru, for example, the study authors project that if coverage of MSM interventions and antiretroviral therapies (ARVs) remain constant, the number of new HIV infections in the general population will result in nearly 20,000 new infections by 2015. Increasing MSM-specific interventions to 100% coverage and providing HIV-positive MSM with full access to ARVs may dramatically decrease the epidemic in the entire population.

“This report demonstrates the scale, scope, and intensity of the HIV epidemics now underway among MSM in too many countries,” said Chris Beyrer, Director of the Center for Public Health and Human Rights at Johns Hopkins University and lead co-author of the study. “But the findings also make clear that responding to these epidemics can have powerful impacts on global AIDS. It is time to act."

To better protect MSM from HIV risks, the authors recommend a minimum package of essential services, including: counseling, distribution of condoms and other safe sex measures, community-based prevention efforts, HIV testing, and increased use of antiretroviral therapy treatment or ARV. Equally important are policy efforts to decriminalize MSM behavior, institute anti-homophobia policies, and programs to educate health care workers and reduce stigma in health care settings.

The authors also recommend careful evaluation of mainstreaming MSM programs, since laws and policies designed to promote universal access and gender equality for HIV services often do not adequately protect MSM and other sexual minorities. Ensuring community participation in providing essential services for MSM is also critical to producing policies that promote the human rights of MSM and expand their access to HIV testing, treatment, and care.

Summary and full report

Click to learn more about the Center for Public Health and Human Rights at Johns Hopkins




[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Monday, April 4, 2011

African Girls Getting World Bank Cash Deters Sex With 'Sugar Daddies'


Via Bloomberg, by Simon Clark

Young women in sub-Saharan Africa have HIV infection rates up to three times higher than their male peers, largely because of relationships with older "sugar daddies" who give them money in exchange for sex.

The phenomenon contributes significantly to HIV's spread, said Ester Etkin of loveLife, South Africa's largest anti-AIDS group.

A World Bank study in Malawi examined cash incentives among approximately 3,800 females ages 13-22. One group received roughly $10 a month and payment for school fees if they regularly attended class, while the control received no incentives. HIV infection rates at 18-month follow-up were 60 percent lower among girls who were given cash: 1.2 percent, compared with 3 percent. The study also showed a delay in the start of sexual activity among beneficiaries and a decline in the number of partners among those who were sexually active.

Though the study's results are being assessed by a peer-reviewed journal, plans are underway to repeat the experiment elsewhere in Africa, said Mayra Buvinic, director of gender and development at the World Bank. "The potential could be huge to reduce HIV rates in teenage girls," she said.

But some experts question whether cash payouts are an appropriate strategy. "We could end up creating an environment of dependency that cannot be sustained," warned Peter Lamptey, a Family Health International physician practicing in Ghana. "Paying people to influence their sexual behavior won't solve the wider problems of abuse, esteem, neglect and inequality that cause them to get HIV," said Sophie Harman, a senior lecturer at London's City University who has studied World Bank AIDS policies.

Read the rest
 
[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Wednesday, July 7, 2010

New Study: Neither Wealth Nor Poverty are Reliable Predictors of HIV Infection in Africa

Via PlusNews

A new study has challenged widely held assumptions about income level in relation to HIV, finding that neither wealth nor poverty are reliable predictors of HIV infection in Africa.

Previously, the argument that poverty drove HIV epidemics was supported by the World Bank and UNAIDS, as well as less reliable authorities like former South African President Thabo Mbeki, who told the International AIDS Conference in Durban in 2000 that the disease was a partner with "poverty, suffering, social disadvantage and inequity".

More recent research suggests that the reality is far more complex. For example, Botswana and South Africa, described as two of the wealthiest countries on the continent, also have among the highest rates of HIV infection.

For the full study (published in the July issue of the Bulletin of the World Health Organization) click here.

Wednesday, July 22, 2009

Funding for rectal microbicides has DECREASED in two years

According to the latest report just released by the HIV Vaccines and Microbicides Resource Tracking Working Group, funding for rectal microbicides research has decreased significantly in the past 2 years.

When IRMA last tracked resources dedicated to RM research in 2006, we estimated that US$7.2 million was spent globally. According to the report Adapting to Realities: Trends in HIV Prevention Research Funding 2000-2008, released earlier this week, that amount decreased to US$5 million in 2008.

7X more funding needed
In 2006, IRMA called for a five-fold increase in annual funding for rectal microbicide research and development: from about US$7 million to US$35 million per year for the next 10 years. This is what we estimated would be needed – conservatively – to bring at least one effective rectal microbicide through all stages of research.

Now, we need a seven-fold increase from US$5 million to US$35 million.

More diverse funding needed
Nearly 100% of all global investment for rectal microbicides development comes from one source: US public and philanthropic institutions. Most of this US investment comes from the government. While this support is appreciated, a much more diverse funding base is needed.

Where are the governments and research institutions? Where are the foundations?

Australia?
Belgium?
Canada?
Denmark?
France?
Germany?
Ireland?
The Netherlands?
Norway?
Spain?
Sweden?
The UK?
The European Commission?
The Bill & Melinda Gates Foundation?
The Rockefeller Foundation?
UNFPA?
The World Bank?

All of them have contributed to microbicides research, for which we are eternally grateful. But they should also contribute specifically to rectal microbicide research. The entire rectal microbicides field should not be funded solely by the US NIH and amfAR.

Recognised need
It is ironic that in the same time period that saw rectal microbicides become increasingly recognised as an essential component of HIV prevention research, global investment faltered.

Investment in rectal microbicide development MUST INCREASE at this critical time when the HIV prevention field is more willing than ever to acknowledge the need to address the prevention needs of those who engage in anal sex: heterosexual women and men, gay men and other men who have sex with men from around the world – including in Africa, Latin America and the Caribbean, Asia-Pacific, Europe and North America.

Funds needed to move research agenda forward
Exciting research projects are ready to move forward: rectal safety trials, rectal-specific formulation work, lubricant safety, acceptability research, research into incidence, prevalence and context of anal intercourse in various populations around the world. More funding is desperately needed to maintain a robust research agenda.










Read the HIV Vaccines and Microbicides Resource Tracking Working Group report: Adapting to Realities: Trends in HIV Prevention Research Funding 2000-2008








Read IRMA’s 2008 report: Less Silence, More Science: Advocacy to Make Rectal Microbicides a Reality





Join efforts to advocate for more investment in rectal microbicide development!
Related Posts Plugin for WordPress, Blogger...